Changes in the regional and compartmental distribution of FosB- and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic L-DOPA treatment

Neuroscience

Volumn 94, Issue 2, 1999, Pages 515-527

  Cenci, M A ^a   Tranberg, A ^a   Andersson, M ^a   Hilbertson, A ^a  

^a Department of Neurobiology   (Sweden)

Author keywords

Basal ganglia; Chronic Fos related antigens; Dopamine denervation; Dopamine replacement; Immediate early genes; Somatostatin NPY interneurons

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; DEXAMPHETAMINE; LEVODOPA; OXIDOPAMINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; FEMALE; GENE EXPRESSION; IMMEDIATE EARLY GENE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INTERNEURON; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

ANIMALS; CORPUS STRIATUM; DENERVATION; DOPAMINE; DRUG ADMINISTRATION SCHEDULE; EXPLORATORY BEHAVIOR; FEMALE; FUNCTIONAL LATERALITY; LEVODOPA; MOTOR ACTIVITY; OXIDOPAMINE; PARKINSONIAN DISORDERS; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032835969     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00294-8     Document Type: Article

References (52)

1. Andersson M., Hibertson A. and Cenci M. A. (1999) Striatal fosB expression is causally linked with L-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease. Neurobiol. Dis. (in press).
2. Berretta S., Robertson H.A., Graybiel A.M. Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like proteins in the striatum. J. Neurophysiol. 68:1992;767-777.
3. Björklund A. and Lindvall O. (1986) Catecholaminergic brain stem regulatory systems. In Handbook of Physiology, Section 1: The Nervous System (eds Mountcastle V. B., Bloom F. E. and Geiger S. R.), Vol. 4, pp. 155-236. American Physiological Society, Baltimore, MD.
4. Boyson S.J., McGonigle P., Molinoff P.B. Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain. J. Neurosci. 6:1986;3177-3188.
5. Bronstein D.M., Ye H., Pennypacker K.R., Hudson P.M., Hong J.-S. Role of a 35 kDa fos-related antigen (FRA) in the long-term induction of striatal dynorphin expression in the 6-hydroxydopamine lesioned rat. Molec. Brain Res. 23:1994;191-203.
6. Brotchie J. M., Henry B., Hille C. J. and Crossman A. R. (1998) Opioid peptide precursor expression in animal models of dystonia secondary to dopamine-replacement therapy in Parkinson's disease. In Advances in Neurology, Dystonia 3 (eds Fahn S., Marsden C. D. and DeLong M. R.), Vol. 78, pp. 41-52. Lippincott-Raven, Philadelphia, PA.
7. Carey R.J. Chronic L-DOPA treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance. Brain Res. 568:1991;205-214.
8. Cenci M.A., Björklund A. Transection of corticostriatal afferents reduces amphetamine- and apomorphine-induced striatal Fos expression and turning behavior in unilaterally 6-hydroxydopamine-lesioned rats. Eur. J. Neurosci. 5:1993;1062-1070.
9. Cenci M.A., Lee C.S., Björklund A. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. Eur. J. Neurosci. 10:1998;2694-2706.
10. Cenci-Nilsson M.A., Tranberg A., Hilbertson A., Andersson M. L-DOPA-induced expression of FosB-related proteins in the dopamine-denervated rat striatum: compartmental and cellular phenotypes, correlations with dyskinesia. Soc. Neurosci. Abstr. 2:1998;1646.
11. Chen J., Kelz M.B., Hope B.T., Nakabeppu Y., Nestler E.J. Chronic Fos-related antigens: stable variants of DFosB induced in brain by chronic treatments. J. Neurosci. 17:1997;4933-4941.
12. Chen J., Nye H.E., Kelz M.B., Hiroi N., Nakabeppu Y., Hope B.T., Nestler E.J. Regulation of ΔFosB and FosB-like proteins by electroconvulsive seizure and cocaine treatments. Molec. Pharmac. 48:1995;880-889.
13. Cole D.G., Growdon J.H., DiFiglia M. Levodopa induction of Fos immunoreactivity in rat brain following partial and complete lesions of the substantia nigra. Expl Neurol. 120:1993;223-232.
14. Conti L., De Fraja C., Gulisano M., Migliaccio E., Govoni S., Cattaneo E. Expression and activation of SH2/PTB-containing ShcA adaptor protein reflects the pattern of neurogenesis in the mammalian brain. Proc. natn. Acad. Sci. U.S.A. 94:1997;8185-8190.
15. Donoghue J.P., Herkenham M. Neostriatal projections from individual cortical fields conform to histochemically distinct striatal compartments in the rat. Brain Res. 365:1986;397-403.
16. Doucet J.-P., Nakabeppu Y., Bedard P.J., Hope B.T., Nestler E.J., Jasmin B.J., Chen J.-S., Iadarola M.J., St-Jean M., Wigle N., Blanchet P., Grondin R., Robertson G.S. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of delta-FosB-like proteins in both the rodent and primate striatum. Eur. J. Neurosci. 8:1996;365-381.
17. Flaherty A. W. and Graybiel A. M. (1994) Anatomy of the basal ganglia. In Movement Disorders 3 (eds Marsden C. D. and Fahn S.), Vol. 3. Butterworth-Heinemann, Cambridge.
18. Gerfen C.R. The neostriatal mosaic: compartmentalization of corticostriatal input and striatonigral output systems. Nature. 311:1984;461-464.
19. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci. 15:1992;133-139.
20. Gerfen C.R., McGinty J.F., Young III W.S. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J. Neurosci. 11:1991;1016-1031.
21. Goldbloom L.M., Brown L.L., Smith D.M., Graybiel A.M. The regional distribution of calbindin and its relationship to striosomes in the rat neostriatum. Soc. Neurosci. Abstr. 23:1997;1284.
22. Graybiel A.M. Building action repertoires: memory and learning functions of the basal ganglia. Curr. Opin. Neurobiol. 5:1995;733-741.
23. Graybiel A.M., Moratalla R., Robertson H.A. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. natn. Acad. Sci. U.S.A. 87:1990;6912-6916.
24. Gundersen H.J.G., Jensen E.B. The efficiency of systematic sampling in stereology and its predictions. J. Microsc. 147:1987;229-263.
25. Herve D., Levi-Strauss M., Marey-Semper I., Verney C., Tassin J.P., Glowinski J., Girault G.A. G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptors with adenylyl cyclase. J. Neurosci. 13:1993;2237-2248.
26. Hope B.T. Cocaine and the AP-1 transcription factor complex. Ann. N. Y. Acad. Sci. 844:1998;1-6.
27. Hope T.B., Nye H.E., Kelz M.B., Self D.W., Iadarola M.J., Nakabeppu Y., Duman R.S., Nestler E.J. Induction of a long-lasting AP1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron. 13:1994;1235-1244.
28. Kawaguchi Y., Wilson C.J., Augood S.J., Emson P.C. Striatal interneurons: chemical, physiological and morphological characterization. Trends Neurosci. 18:1995;527-535.
29. Kincaid A., Wilson C.J. Corticostriatal innervation of the patch and matrix in the rat neostriatum. J. comp. Neurol. 374:1996;578-592.
30. Konradi C., Leveque J.C., Hyman S.E. Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J. Neurosci. 16:1996;4231-4239.
31. LaHoste G.J., Marshall J.F. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density. Synapse. 12:1992;14-26.
32. Le Moine C., Normand E., Bloch B. Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. Proc. natn. Acad. Sci. U.S.A. 88:1991;4205-4209.
33. Le Moine C., Normand E., Guitteny A.F., Foque B., Teoule R., Bloch B. Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proc. natn. Acad. Sci. U.S.A. 87:1990;230-234.
34. Mandelzys A., Gruda M.A., Bravo R., Morgan J.I. Absence of a persistently elevated 37 kDa Fos-realted antigen and AP-1-like binding activity in the brains of kainic acid-treated fosB null mice. J. Neurosci. 17:1997;5407-5415.
35. McGeorge A.J., Faull R.L.M. The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience. 29:1989;503-537.
36. Moratalla R., Elibol B., Vallejo M., Graybiel A.M. Network-level changes in the expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron. 17:1996;147-156.
37. Moratalla R., Vickers E.A., Robertson H.A., Cochran B.H., Graybiel A.M. Coordinate expression of c-fos and jun B is induced in the rat striatum by cocaine. J. Neurosci. 13:1993;423-433.
38. Morgan J.I., Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. A. Rev. Neurosci. 14:1991;421-451.
39. Nakabeppu Y., Nathans D. A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity. Cell. 64:1991;751-759.
40. Narang N., Wamsley J.K. Time dependent changes in DA uptake sites, D1 and D2 receptor binding and mRNA after 6-OHDA lesions of the medial forebrain bundle in the rat brain. J. chem. Neuroanat. 9:1990;41-53.
41. Paul M.L., Graybiel A.M., David J.-C., Robertson H.A. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J. Neurosci. 10:1992;3729-3742.
42. Paxinos G. and Watson C. (1997) The Rat Brain in Stereotaxic Coordinates. Academic, San Diego, CA.
43. Pennypacker K.R., Zhang W.Q., Ye H., Hong J.S. Apomorphine induction of AP-1 DNA binding in the rat striatum after dopamine depletion. Molec. Brain Res. 15:1992;151-155.
44. Pérez-Otaño I., Mandelzys A., Morgan J.I. MPTP-Parkinsonism is accompanied by persistent expression of D-FosB-like proteins in dopaminergic pathways. Molec. Brain Res. 53:1998;41-52.
45. Robertson H.A., Peterson M.R., Murphy K., Robertson G.S. D-1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behavior. Brain Res. 503:1989;346-349.
46. 14C]2-deoxy-D-glucose autoradiography. J. Neurochem. 38:1982;737-748.
47. Schwarzschild M.A., Cole R.L., Hyman S.E. Glutamate, but not dopamine, stimulates stress-activated protein kinase and AP-1-mediated transcription in striatal neurons. J. Neurosci. 17:1997;3455-3466.
48. Ungerstedt U., Arbuthnott G.W. Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigrostriatal system. Brain Res. 24:1970;485-493.
49. Vallone D., Pellecchia M.T., Morelli M., Verde P., DiChiara G., Barone P. Behavioral sensitization in 6-hydroxydopamine-lesioned rats is related to compositional changes of the AP-1 transcription factor: evidence for the induction of FosB- and JunD-related proteins. Molec. Brain Res. 52:1997;307-317.
50. Vincent S.R., Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience. 46:1992;755-784.
51. West M.J., Slomianka L., Gundersen H.J.G. Unbiased stereological estimation of the total number of neurons of the rat hippocampus using the optical fractionator. Anat. Rec. 231:1991;482-497.
52. Zilles K. and Wree A. (1995) Cortex: areal and laminar structure. In The Rat Nervous System (ed. Paxinos G.), 2nd edn, pp. 629-648. Academic, San Diego, CA.